US Patent Issued to Axon Vascular on June 23 for "Devices and methods for treatment of heart failure by splanchnic nerve ablation" (New York, New Jersey Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,177, issued on June 23, was assigned to Axon Vascular Inc. (New York).

"Devices and methods for treatment of heart failure by splanchnic nerve ablation" was invented by Howard Levin (Teaneck, N.J.) and Mark Gelfand (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for treating a heart failure patient by ablating a nerve of the splanchnic sympathetic nervous system to increase venous capacitance and reduce pulmonary blood pressure. A method including: inserting a catheter into a vein adjacent the nerve, applying stimulation energy and observing hemodynamic effects, applying ablation energy and observing hemodynamic effects, applying s...